231 related articles for article (PubMed ID: 14522933)
21. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
[TBL] [Abstract][Full Text] [Related]
22. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
[TBL] [Abstract][Full Text] [Related]
23. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
[TBL] [Abstract][Full Text] [Related]
24. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells.
Frey O; Petrow PK; Gajda M; Siegmund K; Huehn J; Scheffold A; Hamann A; Radbruch A; Bräuer R
Arthritis Res Ther; 2005; 7(2):R291-301. PubMed ID: 15743476
[TBL] [Abstract][Full Text] [Related]
25. Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis.
Woodworth HL; McCaskey SJ; Duriancik DM; Clinthorne JF; Langohr IM; Gardner EM; Fenton JI
Cancer Res; 2010 Oct; 70(20):7960-9. PubMed ID: 20798218
[TBL] [Abstract][Full Text] [Related]
26. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.
Nardelli DT; Burchill MA; England DM; Torrealba J; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1075-84. PubMed ID: 15539509
[TBL] [Abstract][Full Text] [Related]
27. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
28. Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.
Nishikawa H; Kato T; Tawara I; Takemitsu T; Saito K; Wang L; Ikarashi Y; Wakasugi H; Nakayama T; Taniguchi M; Kuribayashi K; Old LJ; Shiku H
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9253-7. PubMed ID: 15961541
[TBL] [Abstract][Full Text] [Related]
29. Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice.
Wei WZ; Jacob JB; Zielinski JF; Flynn JC; Shim KD; Alsharabi G; Giraldo AA; Kong YC
Cancer Res; 2005 Sep; 65(18):8471-8. PubMed ID: 16166327
[TBL] [Abstract][Full Text] [Related]
30. Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a T(h)17-independent manner.
Noguchi D; Wakita D; Tajima M; Ashino S; Iwakura Y; Zhang Y; Chamoto K; Kitamura H; Nishimura T
Int Immunol; 2007 Dec; 19(12):1431-40. PubMed ID: 17981790
[TBL] [Abstract][Full Text] [Related]
31. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
[TBL] [Abstract][Full Text] [Related]
32. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
Li J; Hu P; Khawli LA; Epstein AL
Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
[TBL] [Abstract][Full Text] [Related]
33. Control of immune pathology by regulatory T cells.
Powrie F; Read S; Mottet C; Uhlig H; Maloy K
Novartis Found Symp; 2003; 252():92-8; discussion 98-105, 106-14. PubMed ID: 14609214
[TBL] [Abstract][Full Text] [Related]
34. CD4+CD25+ regulatory T cells and graft-versus-host disease.
Hoffmann P; Edinger M
Semin Hematol; 2006 Jan; 43(1):62-9. PubMed ID: 16412790
[TBL] [Abstract][Full Text] [Related]
35. [Suppressive effect of induced CD4+CD25+ regulatory T cells from mice infected with Schistosoma japonicum].
Tan MJ; Zhang YC; Wang Y; Hu W; Liang YJ; Zhang L
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Jun; 26(3):166-9, 173. PubMed ID: 19160959
[TBL] [Abstract][Full Text] [Related]
36. IL-7 deficiency prevents development of a non-T cell non-B cell-mediated colitis.
von Freeden-Jeffry U; Davidson N; Wiler R; Fort M; Burdach S; Murray R
J Immunol; 1998 Nov; 161(10):5673-80. PubMed ID: 9820548
[TBL] [Abstract][Full Text] [Related]
37. Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope.
Kullberg MC; Andersen JF; Gorelick PL; Caspar P; Suerbaum S; Fox JG; Cheever AW; Jankovic D; Sher A
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15830-5. PubMed ID: 14673119
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic-T-lymphocyte-associated antigen 4 blockade abrogates protection by regulatory T cells in a mouse model of microbially induced innate immune-driven colitis.
Watanabe K; Rao VP; Poutahidis T; Rickman BH; Ohtani M; Xu S; Rogers AB; Ge Z; Horwitz BH; Fujioka T; Erdman SE; Fox JG
Infect Immun; 2008 Dec; 76(12):5834-42. PubMed ID: 18824539
[TBL] [Abstract][Full Text] [Related]
39. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.
Maloy KJ; Salaun L; Cahill R; Dougan G; Saunders NJ; Powrie F
J Exp Med; 2003 Jan; 197(1):111-9. PubMed ID: 12515818
[TBL] [Abstract][Full Text] [Related]
40. Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells.
Maloy KJ; Antonelli LR; Lefevre M; Powrie F
Immunol Lett; 2005 Mar; 97(2):189-92. PubMed ID: 15752557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
